PASG Hisse Senedi Fiyat Grafiği
PASG Hisse Fiyat Tahmini
Passage Bio Inc
$4.4
-4.55%
$-0.2
Kapanışta: Aug 06, 16:00:00 GMT-4
$4.4
0%
$0
Sonrası Piyasa: Aug 06, 17:57:25 GMT-4
Geri
Passage Bio Inc (PASG) Hisse Fiyat Tahmini
Önemli İstatistikler
Önceki Kapanış
$4.61
Açılış fiyatı
$4.5
Günün Aralığı
$4.4 - $4.62
52 haftalık aralık
$3.29 - $20
İşlem hacmi
5.4K
Ort.Hacim
92.8K
Dividend yield
--
EPS (TTM)
-11.84
Piyasa Değeri
$14.1M
PASG nedir?
Passage Bio, Inc. operates as a genetic medicines company. The company is headquartered in Philadelphia, Pennsylvania and currently employs 24 full-time employees. The company went IPO on 2020-02-28. Its lead clinical product candidate, PBFT02, seeks to elevate progranulin levels to enhance lysosomal function and slow disease progression across a variety of neurodegenerative diseases. PBFT02 utilizes an adeno-associated virus serotype 1, or AAV1, capsid to deliver a functional granulin gene, encoding progranulin (PGRN), to the brain via intra cisterna magna (ICM) administration. Its development programs consist of PBFT02 for the treatment of FTD-GRN, PBFT02 for the treatment of FTD-C9orf72 and amyotrophic lateral sclerosis, and PBFT02 for the treatment of Alzheimer’s disease. Its clinical product candidates include PBGM01, PBKR03 and PBML04. The company also has a preclinical research program that explores multiple potential treatment targets for Huntington's disease.
